Title: The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes.
Journal: Archives of toxicology 20180101
114828-90-9
119757-57-2
15917-65-4
164365-20-2
89778-26-7
886465-70-9
1515855-97-6 | JJKK048 | AA01E27E | MFCD30182268
896094-88-5 | 2-(3-bromoimidazo[1,2-a]pyridin-2-yl)acetonitrile | AA01E2LK | MFCD27993637
1839150-56-9 | CHMFL-FLT3-122 | AA01E3D2 | MFCD30182360
27487-35-0 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, [2S-(2α,5α,6β)]-, compd. with N,N′-bis(phenylmethyl)-1,2-ethanediamine (1:1) | AA01X5HG | MFCD00864885
443922-06-3 | 4,4’,4’’-(1,3,5-Triazine-2,4,6-triyl)tris[benzaldehyde] | AA01E4FA | MFCD31631359
62391-98-4 | 2-(1-Methylethyl)-2-propylpropanedioicAcid1,3-DiethylEster | AA01E4T4
82938-05-4 | 17β-Estradiol-13C2 | AA01E5BJ
939040-79-6 | AMG21629 | AA01E5U3 | MFCD29081190
918476-23-0 | 2-(4-Bromophenyl)-5-(trifluoromethyl)-1,3,4-oxadiazole | AA01E6HE | MFCD20486765
173468-29-6 | 4-Nitrophenyl b-D-xylotrioside | AA01E6TJ | MFCD28064292